Recruiting OBSERVATIONAL NCT06300541

Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease

Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease and the Significance of Removing the Colon

Sponsor: Ersta Hospital, Sweden

Conditions Inflammatory Bowel Diseases Sarcopenia

Interventions Colectomy

Updated 5 times since 2024 Last updated: Mar 7, 2024 Started: Apr 1, 2021 Primary completion: May 1, 2027 Completion: Dec 1, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Inflammatory Bowel Diseases and Sarcopenia, this trial is actively recruiting participants. The trial is conducted by Ersta Hospital, Sweden and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Mar 2025 — Present [monthly]

Recruiting
Feb 2025 — Mar 2025 [monthly]

Recruiting
Sep 2024 — Feb 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ersta Hospital, Sweden
Sahlgrenska University Hospital

Data source: Sahlgrenska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gothenburg, Sweden